Effects of a physical activity program and movement-focused care on dependence in daily functions, cognition, physical functions, quality of life related outcomes, and use of medication in nursing home residents with dementia.

Effects of a physical activity program and movement-focused care on activities of daily living, cognition, physical functions, quality of life related outcomes, and use of psychotropic drugs in nursing home residents with dementia: a randomized controlled trial.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON23719

Enrollment

120

Registered

2016-01-12

Start date

2016-01-20

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia, physical activity

Interventions

In the present study, there are two interventions: 1. Physical activity program: combined strength and aerobic training with a duration of 6 months, 3 times a week for 30 minutes. 2. Movement-focuse

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Living on a psychogeriatric ward of stichting tanteLouise-Vivensis 2. Diagnosis of dementia (as stated in the medical status of the person) 3. Mini-Mental State Examination (MMSE) score: 1 - 24 4. Age: at least 65 years 5. Ability to complete the six-minute walking test independently, with or without a walking aid.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Wheelchair bound 2. Severe visual problems 3. Severe cardiovascular problems 4. Instable diabetes mellitus 5. Severe behavioural problems

Design outcomes

Primary

Measure	Time frame
Activities of daily living (ADL): Care Dependency Scale (CDS) and the performance-based Erlangen ADL (E-ADL)	—

Secondary

Measure	Time frame
Cognition: - General cognitive functioning: Severe Impairment Battery (SIB) short version, MMSE (MMSE is not assessed at 3 months, only at baseline and six months) - For participants with a MMSE of 5 or higher: Executive functioning (set-shifting, response inhibition, working memory): Category fluency tests (subtest GIT), Digit span (subtest of WAIS-III), subtests of the Frontal Assessment Battery (FAB; ‘conflicting instructions' and ‘go-no go’) Physical function: - Endurance: six minute walking test (6MWT) - Strength: chair stand test, Jamar dynamometer - Functional mobility: timed up and go (TUG) - Balance: figure of eight walk test (FoE), Figure and Injuries: Cooperative Studies of Intervention Techniques (FICSIT-4) Use of psychotropic drugs: derived from the medical charts Quality of life related outcomes: * Quality of life: Qualidem * Mood and behaviour: - Depression: Cornell Scale for Depression in Dementia (CSDD) - Apathy: Apathy Evaluation Scale-10 (AES-10) - Agitation: Cohen-Mansfield Agitation Inventory (CMAI) * Rest-activity rhythm: actigraphy	—

Measure

Time frame

Cognition: - General cognitive functioning: Severe Impairment Battery (SIB) short version, MMSE (MMSE is not assessed at 3 months, only at baseline and six months) - For participants with a MMSE of 5 or higher: Executive functioning (set-shifting, response inhibition, working memory): Category fluency tests (subtest GIT), Digit span (subtest of WAIS-III), subtests of the Frontal Assessment Battery (FAB; ‘conflicting instructions' and ‘go-no go’) Physical function: - Endurance: six minute walking test (6MWT) - Strength: chair stand test, Jamar dynamometer - Functional mobility: timed up and go (TUG) - Balance: figure of eight walk test (FoE), Figure and Injuries: Cooperative Studies of Intervention Techniques (FICSIT-4) Use of psychotropic drugs: derived from the medical charts Quality of life related outcomes: * Quality of life: Qualidem * Mood and behaviour: - Depression: Cornell Scale for Depression in Dementia (CSDD) - Apathy: Apathy Evaluation Scale-10 (AES-10) - Agitation: Cohen-Mansfield Agitation Inventory (CMAI) * Rest-activity rhythm: actigraphy

—

Contacts

Public ContactI.M. Nauta

Vrije Universiteit Amsterdam - Department of Clinical Neuropsychology

i.m.nauta@vu.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)